• OPEN AN ACCOUNT
Indian Indices
Sensex
74,729.27 413.66
( 0.56%)
Global Indices
Nasdaq
52,025.19 -173.50
(-0.33%)
Dow Jones
7,682.22 -82.84
(-1.07%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,879.96 39.61
(0.37%)
Forex
USD-INR
94.85 -0.23
(-0.24%)
EUR-INR
106.35 0.11
(0.11%)
GBP-INR
125.73 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.07%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
655.111941
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
35.55
50216.1
EPS(TTM)
Face Value()
Div & Yield %
85.6
1
0.66
 

kcd industries india ltd
Moongipa Capital Finance reports standalone net loss of Rs 1.01 crore in the March 2026 quarter
May 14,2026
Net Loss of Moongipa Capital Finance reported to Rs 1.01 crore in the quarter ended March 2026 as against net loss of Rs 0.53 crore during the previous quarter ended March 2025. Sales rose 255.41% to Rs 2.63 crore in the quarter ended March 2026 as against Rs 0.74 crore during the previous quarter ended March 2025.

For the full year,net profit declined 47.10% to Rs 0.73 crore in the year ended March 2026 as against Rs 1.38 crore during the previous year ended March 2025. Sales rose 22.19% to Rs 9.47 crore in the year ended March 2026 as against Rs 7.75 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2.630.74 255 9.477.75 22
OPM %-54.75-45.95 -12.1424.77 -
PBDT-1.60-0.30 -433 0.842.17 -61
PBT-1.62-0.31 -423 0.782.12 -63
NP-1.01-0.53 -91 0.731.38 -47